American Society of Clinical Oncology

SHERPA: White

People

  1. Abou-Alfa
    Abou-Alfa
  2. Harding
    Harding
  3. Saltz
    Saltz
  4. O'Reilly
    O'Reilly
  5. Capanu
    Capanu
  6. Chou
    Chou
  7. Connell
    Connell
  8. D'Angelica
    D'Angelica
  9. Do
    Do
  10. Jarnagin
    Jarnagin

Groups

  1. Center for Pancreatic Cancer Research (6)
  2. Department of Medicine (6)
  3. Epidemiology and Biostatistics (6)
  4. Gastrointestinal Oncology Service (6)
  5. Solid Tumor Oncology Division (6)
  6. Biostatistics Service (4)
  7. Survivorship Research (3)
  8. Advanced Practice Providers (2)
  9. Body Imaging Service (2)
  10. Computational Oncology Service (2)
Search Within
  1. "Ghassan Abou-Alfa"
  2. "Michele Ly"
Formats
  1. Meeting Abstract (6)
Groups
  1. Center for Pancreatic Cancer Research (6)
  2. Department of Medicine (6)
  3. Epidemiology and Biostatistics (6)
  4. Gastrointestinal Oncology Service (6)
  5. Solid Tumor Oncology Division (6)
  6. Biostatistics Service (4)

More Groups

People
  1. Ghassan Abou-Alfa (6)
  2. James Harding (6)
  3. Leonard Saltz (6)
  4. Michele Ly (6)
  5. Eileen O'Reilly (4)
  6. Maeve Lowery (4)

More People

Years
  1. 2016 (2)
  2. 2015 (4)
Publications
  1. Journal of Clinical Oncology (6)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comprehensive molecular profiling and analysis of mutual exclusivity of genetic aberrations (MEGA) of intra- and extrahepatic cholangiocarcinomas (IHC and EHC) evaluation of prognostic features and potential targets for intervention
    Meeting Abstract

    Lowery, M. A.; Ptashkin, R.; Jordan, E.; Berger, M. F.; Zehir, A.; Kemeny, N. E.; O'Reilly, E. M.; Jarnagin, W. R.; Harding, J. J.; DeMatteo, R. P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Identification of potentially actionable molecular alterations in advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    Harding, J. J.; Heins, Z. J.; Connell, L. C.; Soumerai, T.; Kemeny, N. E.; Jarnagin, W. R.; O'Reilly, E. M.; DeMatteo, R. P.; D'Angelica, M. I.; Lowery, M. A.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A phase I trial of binimetinib in combination with gemcitabine (G) and cisplatin (C) patients (pts) with untreated advanced biliary cancer (ABC)
    Meeting Abstract

    Lowery, M. A.; O'Reilly, E. M.; Harding, J. J.; Salehi, E.; Hollywood, E.; Bradley, M.; Sophos, N. A.; Ly, M.; Capanu, M.; Gerst, S. R.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Hepatocellular carcinoma (HCC) and bone metastases (Mets)
    Meeting Abstract

    Harding, J. J.; Abu Zeinah, G.; Chou, J. F.; Owen, D. H.; Ly, M.; Lowery, M. A.; O'Reilly, E. M.; Capanu, M.; Saltz, L.; Abou-Alfa, G. K.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • First stage results of a phase II trial of sorafenib plus doxorubicin (SD) in patients (pts) with advanced hepatocellular carcinoma (HCC) who progressed (POD) on sorafenib (S)
    Meeting Abstract

    Abou-Alfa, G. K.; Capanu, M.; Do, R. K. G.; Hollywood, E.; Ly, M.; Chou, J. F.; Lee, J. K.; Connell, L. C.; Wan, P. J.; Bradley, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Randomized phase II study of everolimus (E), leuprolide + letrozole (LL), and E + LL (ELL) in patients (pts) with unresectable fibrolamellar carcinoma (FLC)
    Meeting Abstract

    Abou-Alfa, G. K.; Mayer, R. J.; Cosgrove, D.; Capanu, M.; Choti, M. A.; Atreya, C. E.; Ang, C.; Kelley, R. K.; Do, R. K. G.; Gordan, J. D.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save